Page 197 - Grow from Within Mastering Corporate Entrepreneurship and Innovation
P. 197

182   grow from within


              defined job, and people may not feel inclined to devote more
              time and energy to the needs of the leader of a prerevenue
              business that is not connected to their typical responsibilities.
                 While rejection is often an active process, new businesses can
              also sometimes fall victim to benign neglect. Indifferent or
              well-meaning people may fail to provide assistance when the
              corporate entrepreneurship team needs it. Only senior man-
              agement has the resources to overcome both active resistance
              and benign neglect, and this antirejection effort must persist
              throughout the development and launch phases of the new
              business. A new business is never safe until it has proven its
              financial impact on the firm’s top and bottom lines.
                 In many ways, new business creation within an existing
              firm is analogous to a human organ transplant. Following an
              organ transplant, the human immune system quickly recog-
              nizes the implanted organ as a foreign object and attempts to
              isolate or destroy it. Without the ongoing administration of
              powerful antirejection drugs, the host body will reject the
              organ, even at the expense of its own survival. Without a
              proper cultural context, structures, and processes, established,
              complex corporations will ferret out foreign entities in much
              the same manner.
                 Those precious few firms that have been able to foster entre-
              preneurship across the company, such as the Google and
              Whirlpool cases we examined earlier, provide the exceptions
              that prove the rule. Even in these cases, we observe a cultural
              substrate that is supportive of entrepreneurial activity and a
              top management consensus regarding new business creation
              as a focal objective of the firm. Ultimately, only top manage-
              ment can administer the medicine that is necessary to avoid
              rejection. While proper structures and processes go a long way,
              maintaining the firm’s focus, effecting culture change, and
              maintaining the right cultural environment for corporate entre-
   192   193   194   195   196   197   198   199   200   201   202